Who is the CEO of E-therapeutics Plc?

The CEO of E-therapeutics Plc is Ahmad Ali Mortazavi.

What industry does E-therapeutics Plc belong to?

E-therapeutics Plc operates in the Biotechnology industry within the Healthcare sector.

Where is E-therapeutics Plc headquartered?

E-therapeutics Plc is headquartered at 4 Kingdom Street, London, W2 6BD, GB.

What is the IPO date of E-therapeutics Plc?

E-therapeutics Plc went public on November 28, 2007.

How many employees does E-therapeutics Plc have?

E-therapeutics Plc has approximately 34 full-time employees.

E-therapeutics Plc

ETX.L•LSE

Healthcare

Biotechnology

£9.00

£-0.65(-6.74%)

E-therapeutics Plc (ETX.L) Company Profile & Overview

Explore E-therapeutics Plc’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

E-therapeutics Plc (ETX.L) Company Profile & Overview

e-Therapeutics plc engages in drug discovery research activities in the United Kingdom. Its computational platform provides in silico screens generate predictions on compounds and/or targets that can have a significant perturbative effect on the biology of interest, captured by its network models, as well as developing RNAi platform for highly specific gene silencing. The company was incorporated in 2001 and is based in London, the United Kingdom.

SectorHealthcare

IndustryBiotechnology

CEOAhmad Ali Mortazavi

Contact Information

https://www.etherapeutics.co.uk

44 20 4551 8888

4 Kingdom Street, London, W2 6BD

Company Facts

34 Employees

IPO DateNov 28, 2007

CountryGB

Frequently Asked Questions

;